- “Fluticasone Furoate Nasal Spray” already exists in your wishlist
In Stock
Imatinib Mesylate Tablets
Imatinib Mesylate Tablets 400mg | Anti-Cancer
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic medicine information • Updated 16 October 2026
Important: This is an educational guide, not a prescription or a substitute for advice from your cancer specialist.
Product Introduction
Imatinib mesylate is a targeted anticancer medicine. The 400 mg strength is used for certain cancers and blood or bone-marrow disorders when the diagnosis and treatment plan indicate that imatinib is appropriate.
This medicine is prescription-only and must be managed by an oncologist or another specialist. The exact indication, dose and duration depend on the condition, test results, response to treatment and tolerability.
1. Uses
May be prescribed for selected cases of chronic myeloid leukaemia (CML), acute lymphoblastic leukaemia (ALL), gastrointestinal stromal tumours (GIST), and certain less common conditions such as dermatofibrosarcoma protuberans or specific forms of systemic mastocytosis.
Not every patient with these conditions is suitable for imatinib. Use is based on the precise diagnosis, disease markers and the treating specialist’s judgement.
2. Benefits
Targets abnormal signalling proteins involved in the growth of certain cancer cells.
Can help control disease, reduce or slow abnormal cell growth, and improve outcomes in patients whose condition is sensitive to imatinib.
Benefit and response vary by diagnosis and individual patient; regular clinical review and laboratory monitoring are essential.
3. Side Effects
Common side effects can include swelling or fluid retention, nausea, vomiting, diarrhoea, abdominal discomfort, muscle cramps, muscle/joint/bone pain, rash, tiredness and headache.
Seek urgent medical help for difficulty breathing or facial/throat swelling; severe or rapidly worsening swelling or rapid weight gain; unusual bleeding or bruising; fever or signs of infection; yellow skin/eyes or dark urine; severe abdominal pain; or a severe blistering/peeling rash.
Serious effects can include low blood-cell counts, liver problems, significant fluid retention, bleeding, severe skin reactions and, rarely, heart problems. Contact the treating team promptly about new or worsening symptoms.
4. Safety Advice
Take only under specialist supervision. Do not start, stop, skip or change the dose without the prescriber’s instructions.
Blood counts, liver function and other tests may be needed before and during treatment. Keep all appointments and report symptoms promptly.
Tell the doctor if you have liver or kidney disease, heart problems, a history of fluid retention, or any ongoing infection.
Pregnancy: imatinib may harm an unborn baby. Tell the specialist if pregnant, planning pregnancy or if pregnancy occurs. Discuss effective contraception and how long it is needed with the treating team.
Breastfeeding is generally not recommended during treatment; ask the specialist when it may be safe to resume.
Use caution with driving or machinery if dizziness, drowsiness or blurred vision occurs. Ask the doctor about alcohol and sun protection; skin may be more sensitive to sunlight.
Keep out of reach of children. Store as directed on the product packaging; the linked product information advises storage below 30°C.
5. How It Works
Imatinib inhibits certain tyrosine kinases, including BCR-ABL and other target kinases in particular diseases. Blocking these signals can reduce the growth and survival of cells that depend on them.
6. How to Use
Follow the exact dose and schedule prescribed for your diagnosis. The 400 mg tablet strength does not mean every patient should take one tablet daily.
Usually taken with a meal and a large glass of water to reduce stomach irritation. Take it at the same time(s) each day as instructed.
Swallow the tablet as directed by the product leaflet. If swallowing is difficult, ask the pharmacist or treating team for approved instructions; do not improvise or alter the tablet without advice.
If you miss a dose or vomit after taking it, contact your treatment team or follow the patient leaflet. Do not double a dose unless specifically instructed.
Do not discontinue treatment because you feel better. The treatment duration is determined by the specialist.
7. Quick Tips
Keep a current list of all prescription medicines, non-prescription medicines, vitamins and herbal products and share it with the oncology team.
Report rapid weight gain, swelling, shortness of breath, unusual bruising/bleeding, fever, or signs of liver problems promptly.
Take the medicine with food and water, and keep a regular routine.
Ask the care team which tests and monitoring schedule apply to you.
8. Drug Interactions
Many medicines can affect imatinib levels or be affected by it. Important examples include strong CYP3A4 inhibitors or inducers, certain antifungals and antibiotics, some seizure medicines, rifampicin, St John’s wort, warfarin and other anticoagulants, and medicines such as atorvastatin.
Do not start or stop any medicine, supplement or herbal product without checking with the prescriber or pharmacist. The examples above are not a complete interaction list; a medication review is important.
Medical Disclaimer
This document is for general educational purposes only and is not a substitute for medical advice, diagnosis or treatment. Imatinib is a specialist-prescribed anticancer medicine. Do not use this guide to select a dose or make treatment decisions. Always follow the current package leaflet and the instructions of your oncologist or pharmacist. In an emergency, seek urgent medical care.
| Product Name | Imatinib Mesylate Tablets |
| Category | All Medicines, Anti Cancer |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 400mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
